Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-18

Clinical Trial Update: Efficacy of Colistin Monotherapy Versus Colistin Plus Minocycline for Carbapenem-Resistant A. Baumannii Infection [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing colistin monotherapy to colistin plus minocycline for carbapenem-resistant Acinetobacter baumannii infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Colistin (colistin)
  • Minocycline (minocycline)

Snippet

Sponsor: Mahidol University | Conditions: Acinetobacter Infections | Phase 4 | Status: UNKNOWN